EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Accuracy of Conventional and Advanced MRI For Histopathological Grading of Glioma

Pamungkas Rahmat Hidayat, Anggraini Dwi Sensusiati, Widiana Ferriastuti

International Journal of Drug Delivery Technology · 14.05.2026 · 16 (43s)

DOI: 10.25258/ijddt.16.43s.74 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.05.2026. Verfasst von Pamungkas Rahmat Hidayat und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma is the most common primary tumor of the central nervous system, with a wide spectrum of malignancy grades based on the 2021 WHO classification integrating histopathological and molecular features. Accurate tumor grading is essential for treatment planning and prognosis. Although histopathology remains the gold standard, it is invasive and subject to sampling bias and inter-observer variability. Multiparametric MRI has emerged as a promising non-invasive alternative. However, most existing studies are derived from large international centers, with limited data from local populations, particularly in Indonesia. In addition, few studies have comprehensively evaluated the combined role of conventional and advanced MRI techniques in direct comparison with histopathological grading within a single institutional setting using the WHO 2021 framework. This study aimed to evaluate the diagnostic performance of conventional and advanced MRI techniques in determining glioma malignancy grade and to assess their agreement with histopathological findings based on the WHO 2021 classification in a local clinical setting. This descriptive analytic cross-sectional study utilized secondary data from glioma patients treated at Dr. Soetomo General Hospital between April 2021 and January 2025. Eligible subjects were adults (≥18 years) with complete multiparametric MRI data including conventional MRI, diffusion-weighted imaging (DWI/ADC), dynamic susceptibility contrast (DSC) perfusion, and magnetic resonance spectroscopy (MRS) as well as histopathological and molecular confirmation based on the 2021 WHO classification. Parameters assessed included contrast enhancement patterns on T1-weighted imaging, ADC values, relative cerebral blood volume (rCBV), and metabolite ratios (Cho/Cr and Cho/NAA). Statistical analyses were conducted to evaluate correlations, sensitivity, and specificity relative to histopathological grading. High-grade gliomas typically showed intense, heterogeneous contrast enhancement accompanied by necrosis. These tumors had significantly lower ADC values compared to low-grade gliomas. In addition, rCBV values were markedly higher in high-grade tumors, indicating increased angiogenesis. Metabolite ratios (Cho/Cr and Cho/NAA) were also elevated in high-grade gliomas. Overall, advanced MRI modalities demonstrated greater sensitivity and specificity than conventional MRI in distinguishing tumor grades. Multiparametric MRI shows a significant correlation with histopathological grading and enhances the accuracy of non-invasive preoperative assessment of glioma malignancy.

Zitieren

APA

Hidayat, P. R., Sensusiati, A. D., & Ferriastuti, W. (2026). Diagnostic Accuracy of Conventional and Advanced MRI For Histopathological Grading of Glioma. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.74

Vancouver

Hidayat PR, Sensusiati AD, Ferriastuti W. Diagnostic Accuracy of Conventional and Advanced MRI For Histopathological Grading of Glioma. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.74

BibTeX
@article{Hidayat2026,
  author = {Hidayat, Pamungkas Rahmat and Sensusiati, Anggraini Dwi and Ferriastuti, Widiana},
  title = {Diagnostic Accuracy of Conventional and Advanced MRI For Histopathological Grading of Glioma},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {43s},
  doi = {10.25258/ijddt.16.43s.74}
}
Kostenlos starten →